Shares of ImmuPharma plc (LON:IMM – Get Free Report) traded down 15.6% during trading on Wednesday . The stock traded as low as GBX 4.60 ($0.06) and last traded at GBX 4.98 ($0.06). 68,204,375 shares changed hands during trading, an increase of 164% from the average session volume of 25,820,418 shares. The stock had previously closed at GBX 5.90 ($0.07).
ImmuPharma Stock Down 15.6 %
The company has a market cap of £20.74 million, a PE ratio of -498.00 and a beta of 1.53. The stock’s 50 day simple moving average is GBX 1.92 and its two-hundred day simple moving average is GBX 1.78.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Further Reading
- Five stocks we like better than ImmuPharma
- How to buy stock: A step-by-step guide for beginners
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Learn Technical Analysis Skills to Master the Stock Market
- 3 Steel Stocks Soaring After Tariff Announcements
- 3 Stocks to Consider Buying in October
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
